Advert - Pharmasure – AUTH/3407/10/20

Promotion of Meriofert/breach of undertaking

For failing to comply with a previous undertaking and continuing to use claims for Meriofert (menotrophin) which had previously been ruled to be in breach of the Code, Pharmasure acknowledged the further following breaches of the Code:


Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry

Clause 29 - Failing to comply with an undertaking